Korean Drug Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9,399	4,886	4,103	11,689	3,426	4,841
Short-Term Investments	25,142	25,111	14,897	5,067	22,990	-
Trading Asset Securities	-	-	-	-	-	23,039
Cash & Short-Term Investments	34,540	29,996	19,000	16,756	26,416	27,881
Cash Growth	34.12%	57.88%	13.39%	-36.57%	-5.25%	25.42%
Accounts Receivable	20,598	23,142	22,813	27,854	31,196	28,501
Other Receivables	10.47	25.94	77.99	154.04	264.21	481.69
Receivables	20,608	23,167	22,891	28,008	31,460	28,983
Inventory	16,483	15,526	20,168	18,341	13,775	12,894
Prepaid Expenses	16.95	29.72	26.21	29.68	15.8	14.88
Other Current Assets	401.79	346.48	841.25	291.26	949.19	677.81
Total Current Assets	72,050	69,066	62,925	63,426	72,617	70,450
Property, Plant & Equipment	20,342	20,653	22,054	22,999	18,607	13,999
Long-Term Investments	186.49	153.79	334.39	261.49	363.89	1,353
Other Intangible Assets	210.7	208.77	208.92	362.8	490.55	263.02
Long-Term Accounts Receivable	0	-	-0	-	-	-
Long-Term Deferred Tax Assets	1,071	1,245	1,208	1,015	1,163	820.32
Other Long-Term Assets	2,534	2,992	2,156	1,645	1,276	1,728
Total Assets	96,394	94,318	88,887	89,709	94,516	88,613
Accounts Payable	3,085	1,243	570.28	1,921	4.55	3,213
Accrued Expenses	2,029	2,100	1,820	1,951	1,896	1,131
Current Portion of Leases	56.03	43.29	63.05	51.31	59.47	39.07
Current Income Taxes Payable	550.41	899.86	442.95	2,192	1,499	2,151
Other Current Liabilities	5,152	4,006	4,314	3,786	3,953	3,796
Total Current Liabilities	10,872	8,292	7,210	9,902	7,412	10,329
Long-Term Leases	27.04	14.55	17.91	16.26	21.73	15
Pension & Post-Retirement Benefits	-	-	-	345.17	263.64	-
Other Long-Term Liabilities	3,189	2,941	3,553	2,355	2,107	1,579
Total Liabilities	14,088	11,247	10,781	12,619	9,804	11,923
Common Stock	5,500	5,500	5,500	5,500	5,500	5,500
Additional Paid-In Capital	3,355	3,366	3,375	3,430	3,431	3,430
Retained Earnings	74,741	75,529	70,591	69,724	77,364	69,345
Treasury Stock	-1,290	-1,323	-1,360	-1,563	-1,583	-1,586
Comprehensive Income & Other	-0	-0	0	-0	-0	0
Shareholders' Equity	82,306	83,072	78,106	77,090	84,713	76,690
Total Liabilities & Equity	96,394	94,318	88,887	89,709	94,516	88,613
Total Debt	83.07	57.84	80.97	67.57	81.2	54.07
Net Cash (Debt)	34,457	29,939	18,919	16,688	26,335	27,826
Net Cash Growth	34.16%	58.25%	13.37%	-36.63%	-5.36%	25.47%
Net Cash Per Share	-	2767.49	1753.14	1547.64	2442.18	2546.94
Filing Date Shares Outstanding	-	10.82	10.81	10.79	10.78	10.78
Total Common Shares Outstanding	-	10.82	10.81	10.79	10.78	10.78
Working Capital	61,178	60,774	55,715	53,524	65,205	60,121
Book Value Per Share	-	7677.85	7222.25	7146.81	7855.42	7111.75
Tangible Book Value	82,095	82,863	77,897	76,727	84,222	76,427
Tangible Book Value Per Share	-	7658.56	7202.93	7113.17	7809.93	7087.35
Land	7,494	7,494	7,494	7,681	7,681	5,748
Buildings	6,220	14,955	14,955	14,955	11,264	11,264
Machinery	5,472	11,687	11,639	9,974	7,215	7,387
Construction In Progress	68.45	68.45	-	969.41	3,376	-